| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy &Dev. Officer
1 company
Desai Veeral is a Chief Strategy &Dev. Officer at AGL. Recent filings cover 1 purchase and 17 sales.
Our model assigns Desai Veeral a strong insider score of 70/100, based on 16 past trades. Over a 12-month horizon, 62.5% of those trades were profitable, with an average 12-month return of +28.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Buy | 11,956 | $0.00 | - | +4.0% | +31.5% | -22.6% | |
| May 9, 2023 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE10b5-1 | 4,500 | $26.15 | $117,665.55 | -1.5% | -22.6% | -80.0% | |
| Apr 20, 2023 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE10b5-1 | 5,500 | $26.84 | $147,617.74 | -1.8% | -27.2% | -78.1% | |
| Mar 24, 2023 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 120,000 | $28.70 | $3,444,289.65 | -30.2% | -41.7% | -83.0% | |
| Mar 16, 2023 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 60,000 | $26.09 | $1,565,196.00 | -17.8% | -28.2% | -79.6% | |
| Jul 21, 2022 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 79,768 | $27.50 | $2,193,620.00 | -22.3% | -28.2% | -33.2% | |
| Jul 7, 2022 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 319,071 | $25.00 | $7,976,775.00 | -53.4% | -7.8% | -36.3% | |
| Jun 24, 2022 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 106,357 | $22.50 | $2,393,032.50 | -27.7% | +2.1% | -22.2% | |
| Apr 22, 2022 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 106,357 | $20.40 | $2,169,951.73 | -27.7% | +46.4% | +33.2% | |
| Apr 20, 2022 | AGL Agilon Health, Inc. | Chief Strategy &Dev. Officer | Sale+OE | 212,714 | $22.54 | $4,794,573.56 | -43.3% | +19.6% | +14.9% |